سعر سولفوليتك 8مجم/5مل شراب 115 مل 2022

Solvolytic 8 mg/5 ml syrup, 115 ml (CID, Egypt): bromhexine oral syrup, a mucolytic.

• Uncommon: upper abdominal pain, nausea, vomiting, diarrhoea.General active-ingredient information · Health Products Regulatory Authority (HPRA), Ireland
• Rare: hypersensitivity reactions, rash, urticaria. Not known: anaphylactic reactions including shock, bronchospasm, pruritus, angioedema, severe cutaneous adverse reactions.General active-ingredient information · Health Products Regulatory Authority (HPRA), Ireland

• Hypersensitivity to bromhexine or to any excipient.General active-ingredient information · Health Products Regulatory Authority (HPRA), Ireland

• Use with caution in patients with a history of, or existing, peptic ulceration.General active-ingredient information · Health Products Regulatory Authority (HPRA), Ireland
• Severe skin reactions (erythema multiforme, Stevens-Johnson syndrome/toxic epidermal necrolysis, acute generalised exanthematous pustulosis) have been reported; stop immediately and seek medical advice if a progressive rash, possibly with blisters or mucosal lesions, appears.General active-ingredient information · Health Products Regulatory Authority (HPRA), Ireland

• Antibiotics (amoxicillin, erythromycin, oxytetracycline, ampicillin)No clinically relevant unfavourable interactions have been reported; bromhexine increases antibiotic concentrations in sputum and bronchopulmonary secretions.Health Products Regulatory Authority (HPRA), Ireland

• Limited data in pregnant women; preclinical studies show no harmful reproductive effects. As a precaution it is preferable to avoid use during pregnancy.General active-ingredient information · Health Products Regulatory Authority (HPRA), Ireland
• Unknown whether excreted in human milk; preclinical data show excretion into milk and a risk to the infant cannot be excluded. Should not be used during breastfeeding.General active-ingredient information · Health Products Regulatory Authority (HPRA), Ireland

• Bromhexine: Synthetic derivative of vasicine; increases the proportion of serous bronchial secretion and enhances mucus transport by reducing mucus viscosity and activating the ciliated epithelium (mucociliary clearance).